These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12578152)

  • 1. Lack of effect of food on the bioavailability of a new ketolide antibacterial, telithromycin.
    Bhargava V; Lenfant B; Perret C; Pascual MH; Sultan E; Montay G
    Scand J Infect Dis; 2002; 34(11):823-6. PubMed ID: 12578152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and absolute oral bioavailability of an 800-mg oral dose of telithromycin in healthy young and elderly volunteers.
    Perret C; Lenfant B; Weinling E; Wessels DH; Scholtz HE; Montay G; Sultan E
    Chemotherapy; 2002 Dec; 48(5):217-23. PubMed ID: 12476037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses.
    Namour F; Wessels DH; Pascual MH; Reynolds D; Sultan E; Lenfant B
    Antimicrob Agents Chemother; 2001 Jan; 45(1):170-5. PubMed ID: 11120961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.
    Shi J; Montay G; Chapel S; Hardy P; Barrett JS; Sack M; Marbury T; Swan SK; Vargas R; Leclerc V; Leroy B; Bhargava VO
    J Clin Pharmacol; 2004 Mar; 44(3):234-44. PubMed ID: 14973302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
    Shi J; Montay G; Bhargava VO
    Clin Pharmacokinet; 2005; 44(9):915-34. PubMed ID: 16122280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).
    Muller-Serieys C; Soler P; Cantalloube C; Lemaitre F; Gia HP; Brunner F; Andremont A
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3104-8. PubMed ID: 11600363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of food on the pharmacokinetics of rifalazil, a novel antibacterial, in healthy male volunteers.
    Chen YX; Cabana B; Kivel N; Michaelis A
    J Clin Pharmacol; 2007 Jul; 47(7):841-9. PubMed ID: 17463218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bioequivalence of telithromycin administered orally as crushed tablets versus tablets swallowed whole.
    Lippert C; Gbenado S; Qiu C; Lavin B; Kovacs SJ
    J Clin Pharmacol; 2005 Sep; 45(9):1025-31. PubMed ID: 16100296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment.
    Cantalloube C; Bhargava V; Sultan E; Vacheron F; Batista I; Montay G
    Int J Antimicrob Agents; 2003 Aug; 22(2):112-21. PubMed ID: 12927950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of telithromycin (HMR 3647), a new ketolide antimicrobial, into inflammatory blister fluid following oral administration.
    Namour F; Sultan E; Pascual MH; Lenfant B
    J Antimicrob Chemother; 2002 Jun; 49(6):1035-8. PubMed ID: 12039900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
    Guivarc'h PH; Vachon MG; Fordyce D
    Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
    Lorenz J
    Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections.
    Ciervo CA; Shi J
    Curr Med Res Opin; 2005 Oct; 21(10):1641-50. PubMed ID: 16238904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora.
    Edlund C; Alván G; Barkholt L; Vacheron F; Nord CE
    J Antimicrob Chemother; 2000 Nov; 46(5):741-9. PubMed ID: 11062193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue kinetics of telithromycin, the first ketolide antibacterial.
    Muller-Serieys C; Andrews J; Vacheron F; Cantalloube C
    J Antimicrob Chemother; 2004 Feb; 53(2):149-57. PubMed ID: 14729764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults.
    Musson DG; Kramer WG; Foehr ED; Bieberdorf FA; Hornfeldt CS; Kim SS; Dorenbaum A
    Clin Ther; 2010 Feb; 32(2):338-46. PubMed ID: 20206791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single and repeated oral doses of telithromycin on cardiac QT interval in healthy subjects.
    Démolis JL; Vacheron F; Cardus S; Funck-Brentano C
    Clin Pharmacol Ther; 2003 Mar; 73(3):242-52. PubMed ID: 12621389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.